Nabil Chehab, Lung Cancer Medical Franchise Head and Executive Medical Director, US Medical Affairs at AstraZeneca, shared on LinkedIn:
“Whether a lung cancer patient receives support to navigate their care journey should not depend on where they live.
But right now, in too many places, it does.
A landmark new consensus statement from the lung cancer community is calling for that to change, recommending that patient navigation be made standard, sustainable and universally accessible across the lung cancer care pathway.
I’m proud to be part of AstraZeneca and committed to making this a reality.”
Read the full statement:
